Free Trial

The Biotech Growth Trust (BIOG) Competitors

The Biotech Growth Trust logo
GBX 888 -8.00 (-0.89%)
As of 08/29/2025 12:14 PM Eastern

BIOG vs. JPE, TMPL, OCI, BBGI, APAX, ICGT, IEM, RICA, CGT, and MUT

Should you be buying The Biotech Growth Trust stock or one of its competitors? The main competitors of The Biotech Growth Trust include JPMorgan Elect plc ­- Managed Growth (JPE), Temple Bar (TMPL), Oakley Capital Investments (OCI), BBGI Global Infrastructure (BBGI), Apax Global Alpha (APAX), ICG Enterprise Trust (ICGT), Impax Environmental Markets (IEM), Ruffer Investment (RICA), Capital Gearing (CGT), and Murray Income Trust (MUT). These companies are all part of the "asset management" industry.

The Biotech Growth Trust vs. Its Competitors

The Biotech Growth Trust (LON:BIOG) and JPMorgan Elect plc ­- Managed Growth (LON:JPE) are both small-cap asset management industry companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, media sentiment, profitability, institutional ownership, dividends, earnings, analyst recommendations and valuation.

The Biotech Growth Trust has a net margin of 95.33% compared to JPMorgan Elect plc ­- Managed Growth's net margin of 0.00%. The Biotech Growth Trust's return on equity of 26.96% beat JPMorgan Elect plc ­- Managed Growth's return on equity.

Company Net Margins Return on Equity Return on Assets
The Biotech Growth Trust95.33% 26.96% 12.39%
JPMorgan Elect plc ­- Managed Growth N/A N/A N/A

10.5% of The Biotech Growth Trust shares are held by institutional investors. 1.8% of The Biotech Growth Trust shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

The Biotech Growth Trust has higher earnings, but lower revenue than JPMorgan Elect plc ­- Managed Growth. The Biotech Growth Trust is trading at a lower price-to-earnings ratio than JPMorgan Elect plc ­- Managed Growth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
The Biotech Growth Trust-£78.81M-2.80£83.83M-£2.62-338.54
JPMorgan Elect plc ­- Managed Growth£104.78M0.00N/A£0.75N/A

In the previous week, The Biotech Growth Trust's average media sentiment score of 0.63 beat JPMorgan Elect plc ­- Managed Growth's score of 0.00 indicating that The Biotech Growth Trust is being referred to more favorably in the media.

Company Overall Sentiment
The Biotech Growth Trust Positive
JPMorgan Elect plc ­- Managed Growth Neutral

Summary

The Biotech Growth Trust beats JPMorgan Elect plc ­- Managed Growth on 6 of the 9 factors compared between the two stocks.

Get The Biotech Growth Trust News Delivered to You Automatically

Sign up to receive the latest news and ratings for BIOG and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BIOG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BIOG vs. The Competition

MetricThe Biotech Growth TrustAsset Management IndustryFinancial SectorLON Exchange
Market Cap£215.29M£1.46B£6.35B£2.79B
Dividend YieldN/A4.61%4.33%5.32%
P/E Ratio-338.544,455.541,695.825,162.88
Price / Sales-2.801,990.791,383.36101,256.49
Price / Cash87.7460.62127.5927.93
Price / Book0.821.393.736.30
Net Income£83.83M£265.04M£1.23B£5.89B
7 Day Performance-0.22%0.33%0.02%0.19%
1 Month Performance6.47%1.67%2.65%49.33%
1 Year Performance-12.25%6.79%26.98%153.42%

The Biotech Growth Trust Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BIOG
The Biotech Growth Trust
N/AGBX 888
-0.9%
N/A-12.1%£215.29M-£78.81M-338.54N/A
JPE
JPMorgan Elect plc ­- Managed Growth
N/AN/AN/AN/A£1.00B£104.78M1,250.00N/A
TMPL
Temple Bar
N/AGBX 345.63
+0.8%
N/A+25.8%£988.77M£157.64M6.42N/A
OCI
Oakley Capital Investments
N/AGBX 560
+0.7%
N/A+7.6%£987.90M£99.08M11.22N/A
BBGI
BBGI Global Infrastructure
N/AGBX 138.50
flat
N/AN/A£984.71M£67.98M17.931,160
APAX
Apax Global Alpha
N/AGBX 163.62
+0.0%
N/A+12.5%£955.29M£9.05M277.59N/A
ICGT
ICG Enterprise Trust
N/AGBX 1,456
+0.4%
N/A+16.4%£940.99M£55.63M29.07N/ANews Coverage
Positive News
IEM
Impax Environmental Markets
N/AGBX 398
+0.4%
N/A+2.7%£923.96M£1.35M-99.00N/ANews Coverage
RICA
Ruffer Investment
N/AGBX 284.47
+0.2%
N/A+2.5%£915.35M£16.91M103.48N/A
CGT
Capital Gearing
N/AGBX 4,843.65
+0.1%
N/A+1.9%£900.79M£17.92M19.69N/A
MUT
Murray Income Trust
N/AGBX 896.69
-0.1%
N/A+1.9%£895.87M£97.96M9.88147,000News Coverage
Dividend Cut

Related Companies and Tools


This page (LON:BIOG) was last updated on 8/30/2025 by MarketBeat.com Staff
From Our Partners